Menu
US
base-editing1920x640
Brochure

A breakthrough aptamer-mediated base editing platform for simultaneous knock-in and multiple gene knockout

In this literature review, find out about an application of gene editing that diverges from the conventional paradigm, offering enhanced safety measures and simplifying the process of effecting complex genetic changes in a streamlined workflow.

You will learn about:

  • The potential of CAR T cell therapy to combat cancer and barriers to overcome
  • How an application of gene editing that diverges from the conventional paradigm can help to address these challenges
  • How this approach provides enhanced safety measures and simplifies the process of effecting complex genetic changes in a streamlined workflow

The Pin-point platform technology is available for clinical study and commercialization under a commercial license from Revvity. Pin-point reagents are available for research use only.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

A breakthrough aptamer-mediated base editing platform for simultaneous knock-in and multiple gene knockout

Download Brochure